Open AccessThe Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study
Author(s) -
Hirokazu Kakuda,
Junji Kobayashi,
Masaru Sakurai,
Masahiro Kakuda,
Noboru Takekoshi
Publication year - 2017
Publication title -
journal of clinical medicine research
Language(s) - English
Resource type - Journals
eISSN - 1918-3011
pISSN - 1918-3003
DOI - 10.14740/jocmr2806w
Subject(s) - postprandial , medicine , type 2 diabetes , lipid metabolism , endocrinology , carbohydrate metabolism , diabetes mellitus
Postprandial hyperglycemia and hyperlipidemia are highly related to the development of atherosclerosis. Sodium/glucose cotransporter-2 (SGLT2) inhibitors have attracted attention as a new class of anti-diabetic agents for the treatment of type 2 diabetes. We investigated the effect of tofogliflozin on postprandial glucose and lipid metabolism in Japanese male patients with type 2 diabetes.